The company lacks an active business model, reporting zero revenue in nine of the last ten quarters and a $363,000 operating loss in 2026Q1.
| Sales/Revenue | 1.2M | - | - | - |
| Revenue Growth % | - | - | - | - |
| Cost of Goods Sold | 0 | - | - | - |
| COGS % of Revenue | - | - | - | - |
| Gross Profit | 601.17K | 0 | 0 | -660K |
| Gross Margin % | 50% | - | - | - |
| Gross Profit Growth % | - | - | 100% | - |
| Operating Expenses | 1.27M | 1.43M | 1.19M | 659.98K |
| OpEx % of Revenue | - | - | - | - |
| Selling, General & Admin | -41.56K | 0 | 0 | 0 |
| SG&A % of Revenue | - | - | - | - |
| Research & Development | 0 | - | - | - |
| R&D % of Revenue | - | - | - | - |
| Other Operating Expenses | 0 | - | - | - |
| Operating Income | -1.78M | -1.43M | -1.19M | -660K |
| Operating Margin % | -148.3% | - | - | - |
| Operating Income Growth % | - | -19.86% | -80.67% | - |
| EBITDA | -972.21K | -1.43M | 4.28M | 3.3M |
| EBITDA Margin % | -80.86% | - | - | - |
| EBITDA Growth % | -113.82% | -133.43% | 29.72% | - |
| D&A (Non-Cash Add-back) | 0 | 0 | 0 | 3.96M |
| EBIT | -609.21K | -1.43M | 4.28M | 3.3M |
| Net Interest Income | -91.3K | -134.33K | -27.97K | 0 |
| Interest Income | 0 | 0 | 0 | 0 |
| Interest Expense | 43.85K | 134.33K | 27.97K | 0 |
| Other Income/Expense | 0 | - | - | - |
| Pretax Income | -910.87K | -1.1M | 4.25M | 3.3M |
| Pretax Margin % | -75.76% | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% |
| Net Income | -910.87K | -1.1M | 4.25M | 3.3M |
| Net Margin % | -75.76% | - | - | - |
| Net Income Growth % | -116.42% | -125.85% | 28.88% | - |
| Net Income (Continuing) | -910.87K | -1.1M | 4.25M | 3.3M |
| Discontinued Operations | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -1.24 | -0.25 | 0.43 | 0.32 |
| EPS Growth % | -153.15% | -158.14% | 34.38% | - |
| EPS (Basic) | - | -0.25 | 0.43 | 1.05 |
| Diluted Shares Outstanding | 737.54K | 963.03K | 9.96M | 10.2M |
| Basic Shares Outstanding | 737.54K | 963.03K | 9.96M | 3.13M |
| Dividend Payout Ratio | - | - | - | - |
Imminent Liquidation or Dilution
As indicated by the provided income statement data, ALCY has generated zero operational revenue in nine of the last ten quarters, with a singular $1.2 million revenue event in 2024Q4, confirming its status as a pre-combination special purpose acquisition vehicle lacking an active business model.
The isolated revenue spike in 2024Q4 appears to be an anomaly rather than a trend, as the company has reverted to zero-revenue reporting in subsequent periods. This lack of consistent top-line growth underscores the speculative nature of the entity, which remains entirely dependent on the successful identification and acquisition of a target firm.
Based on the reported financial figures, ALCY's net income has been consistently decoupled from operational performance, with net income reaching as high as $1.5 million in 2024Q3 despite the company reporting zero revenue and negative operating income during that same period.
The volatility in net income suggests that reported earnings are driven by non-operating items, likely related to warrant liability revaluations or interest income from the trust account. Investors should exercise caution, as these figures provide no insight into the underlying economic health or future profitability of the firm.
According to the income statement, ALCY maintains a lean cost structure dominated by administrative expenses, yet the recent operating loss of $363,000 in 2026Q1 highlights the ongoing cash burn required to maintain the public listing in the absence of any meaningful revenue generation.
The company's inability to offset administrative costs with operational income suggests a high degree of sensitivity to the duration of the search phase. With cash reserves reported at only $55,020, the current cost structure appears unsustainable without either a rapid business combination or further capital injections from the sponsor.
As reported in financial statements, the company's incorporation in 2021 combined with a persistent negative operating income trend suggests that ALCY faces significant pressure to execute a merger before the depletion of its remaining cash reserves forces a liquidation or unfavorable financing terms.
Short-term observers may focus on the potential for a transformative acquisition, but the extended timeline since inception warrants skepticism regarding the sponsor's ability to secure a value-accretive target. The risk of 'deal desperation' remains high, which could lead to a business combination that fails to provide long-term shareholder value.
Quick answers to the most common questions about buying ALCY stock.
Alchemy Investments Acquisition Corp 1 (ALCY) reported a net loss of $1.1M for the fiscal year ending 2025.